Literature DB >> 8474300

[Clinical and functional results of abdominal rectopexy using different fixation principles].

G Winde1, B Reers, A Holzgreve, R Fischer, A Bohlmann, H Bünte.   

Abstract

We report our results with abdominal rectopexy (modified Ripstein procedure, Ripstein/Corman) without resection of the colon in 63 patients using lyophylized dura-strips, Vicryl gauze or Dexon gauze, as the underlying fixation material for the mobilized rectum, presacral fascia and fixation suture material. Forty-five of 64 patients (71.4%) were reevaluated by proctoscopic examination and questioning; the mean follow-up time was 52.5 months (range 3-136 months). Postoperative mortality due to the method was 0%; the mortality was 1.6% (n = 1/63) in general for the first postoperative 30-day period as a result of cardiac complications. There were three complications (4.7%) the durating operation. Postoperative morbidity was 25.4% (16/63); infectious complications occurred in 12.7% (8/63) of cases, with one case of spontaneous closure of a pelvicutaneous fistula after intraoperative injury to the rectal wall. Full-thickness rectal prolapse appeared after rectopexy in 4.4% (2/45) (dura material alone) and mucosal prolapse was seen in 15.5% (7/45) of the follow-up group. Constipation was reduced by 28.6% (18/63) to 22.2% during the follow-up. Seventeen of 28 patients (60.7%) with incontinence showed an improvement; total continence was registered in 35.7% (10/28). The increase in continence as a result of abdominal rectopexy was significant (Wilcoxon, P = 0.05). The special aspects of being in an older age group, having a long history of procidentia, the number of deliveries, the length of the preoperative incontinence period all showed no influence on the postoperative degree of continence (Spearman's rank correlation). In 7/15 cases with persisting incontinence after rectopexy, postanal repair (Parks) was efficient in 7/7 cases leading to total or partial continence.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8474300     DOI: 10.1007/bf00202115

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  47 in total

1.  Sutured posterior abdominal rectopexy with sigmoidectomy compared with Marlex rectopexy for rectal prolapse.

Authors:  J Sayfan; M Pinho; J Alexander-Williams; M R Keighley
Journal:  Br J Surg       Date:  1990-02       Impact factor: 6.939

2.  Experiences of Ivalon-sponge implant for complete rectal prolapse at St. Mark's Hospital, 1960-70.

Authors:  J C Penfold; P R Hawley
Journal:  Br J Surg       Date:  1972-11       Impact factor: 6.939

3.  Procidentia: definitive corrective surgery.

Authors:  C B Ripstein
Journal:  Dis Colon Rectum       Date:  1972 Sep-Oct       Impact factor: 4.585

4.  The surgical treatment of rectal procidentia.

Authors:  H M Frykman; S M Goldberg
Journal:  Surg Gynecol Obstet       Date:  1969-12

5.  [Controlled experimental histological and microbiological studies on the inhibitory effect of polyglycolic acid sutures in infections].

Authors:  A Thiede; L Jostarndt; B Lünstedt; H G Sonntag
Journal:  Chirurg       Date:  1980-01       Impact factor: 0.955

6.  Complications of the Ripstein procedure.

Authors:  P H Gordon; B Hoexter
Journal:  Dis Colon Rectum       Date:  1978 May-Jun       Impact factor: 4.585

7.  Rectal prolapse.

Authors:  D Failes; M Killingback; M Stuart; C De Luca
Journal:  Aust N Z J Surg       Date:  1979-02

8.  Clinical and functional results of abdominal rectopexy for complete rectal prolapse.

Authors:  J L McCue; J P Thomson
Journal:  Br J Surg       Date:  1991-08       Impact factor: 6.939

9.  Abnormalities of colonic function in patients with rectal prolapse and faecal incontinence.

Authors:  M R Keighley; P J Shouler
Journal:  Br J Surg       Date:  1984-11       Impact factor: 6.939

10.  Outcome of colectomy for severe idiopathic constipation.

Authors:  M A Kamm; P R Hawley; J E Lennard-Jones
Journal:  Gut       Date:  1988-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.